Follow-up Roundtable: Discussing Why Dosimetry is a Pillar of Radiopharmaceutical Manufacturing & How Integrating it Early Ensures Patient Safety, Product Consistency & Regulatory Confidence
Time: 10:00 am
day: Conference Day Two
Details:
- Discussing the practical role of dosimetry in Phase 3 trials and commercial settings. When does it add real value, and when does it become an unnecessary burden?
- Exploring industry-wide challenges with standardization and how to ensure consistent and reliable dosimetry across trial sites with varying equipment and expertise.
- Evaluating strategies for improving data quality and whether sponsors should centralize dosimetry efforts, limit to trusted sites, or invest in new technologies to ensure accuracy?
